Paid Clinical Trials in Texas

Texas has 5,347 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: September 17, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,652 clinical trials

Get a weekly email when new trials open in Houston, TX.

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

for Recurrent Head and Neck Squamous Cell Carcinoma

Sites in Houston +6 more locations

Sponsor: Rakuten Medical, Inc.

Sex: All·Age: 18+

Code: NCT06699212·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

for Head and Neck Squamous Cell Carcinoma (HNSCC)

Sites in Houston +3 more locations

Sponsor: Tanabe Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT06943521·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Phase 1/2, Dose-Exploration Study to Evaluate the Safety and Efficacy of BEAM-301 in Patients With Glycogen Storage Disease Type Ia (GSDIa)

for Glycogen Storage Disease Type Ia

Sites in Houston +2 more locations

Sponsor: Beam Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06735755·Phase 1, Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder

for Neuromyelitis Optica Spectrum Disorder

Drug: Inebilizumab

Sites in Dallas +3 more locations

Sponsor: Amgen

Sex: All·Age: 2 - 17

Code: NCT05549258·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

ACE2016 in Adult Subjects With Locally Advanced or Metastatic Solid Tumors Expressing Epidermal Growth Factor Receptor (EGFR)

for Locally Advanced Solid Tumor

Sites in Dallas +3 more locations

Sponsor: Acepodia Biotech, Inc.

Sex: All·Age: 18+

Code: NCT06415487·Phase 1·Recruiting·Listed May 2024

Apply to this trial

A Study of Invikafusp Alfa (STAR0602), a Selective T Cell Receptor (TCR)-Targeting, Bifunctional Antibody-fusion Molecule, in Combination With Sacituzumab Govitecan in Participants With Advanced Solid Tumors

for Triple Negative Locally Advanced Non-resectable Breast Cancer

Sites in San Antonio +5 more locations

Sponsor: Marengo Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06827613·Phase 1, Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Clinical Trial of PM54 in Advanced Solid Tumors Patients.

for Advanced Solid Tumor

1 location in San Antonio

Sponsor: PharmaMar

Sex: All·Age: 18+

Code: NCT05841563·Phase 1·Recruiting·Listed May 2023

Apply to this trial

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Houston, Dallas +5 more locations

Sponsor: LigaChem Biosciences, Inc.

Sex: All·Age: 18+

Code: NCT05941507·Phase 1, Phase 2·Recruiting·Listed Jul 2023

Apply to this trial

Vitaccess Real MG Registry

for Myasthenia Gravis

Sites in Houston +5 more locations

Sponsor: Vitaccess Ltd

Sex: All·Age: 18+

Code: NCT06064461·Recruiting·Listed Oct 2023

Apply to this trial

Lisaftoclax (APG-2575) Combined With Azacytidine (AZA) in the Treatment of Patients With Higher-risk Myelodysplastic Syndrome (GLORA-4).

for Higher-risk Myelodysplastic Syndrome

1 location in Houston

Sponsor: Ascentage Pharma Group Inc.

Sex: All·Age: 18+

Code: NCT06641414·Phase 3·Recruiting·Listed Oct 2024

Apply to this trial

UBX-303061 in Subjects With Relapsed/Refractory B-Cell Malignancies

for Relapsed/Refractory B-cell Malignancies

Sites in Houston +2 more locations

Sponsor: Ubix Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT06590961·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

Study Evaluating UCART20x22 in B-Cell Non-Hodgkin Lymphoma

for B-cell Non-Hodgkin Lymphoma (B-NHL)

Sites in Austin +3 more locations

Sponsor: Cellectis S.A.

Sex: All·Age: 18 - 80

Code: NCT05607420·Phase 1, Phase 2·Recruiting·Listed Nov 2022

Apply to this trial

AMT-116 in Patients With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Dallas +1 more location

Sponsor: Multitude Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT05725291·Phase 1·Recruiting·Listed Feb 2023

Apply to this trial

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

for B-Cell Non-Hodgkin's Lymphoma (NHL)

Sites in Dallas +1 more location

Sponsor: Estrella Biopharma, Inc.

Sex: All·Age: 18+

Code: NCT06343311·Phase 1, Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

Reducing Fluid Overload in Heart Failure Patients Using a Non-invasive, Renal Independent System

for Chronic Heart Failure

Sites in Austin +7 more locations

Sponsor: AquaPass Medical Ltd.

Sex: All·Age: 21 - 79

Code: NCT06360380·Recruiting·Listed Apr 2024

Apply to this trial

A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data

for Cancer

Sites in Houston +6 more locations

Sponsor: N-Power Medicine

Sex: All·Age: 18 - 120·Accepts healthy volunteers

Code: NCT06877884·Recruiting·Listed Mar 2025

Apply to this trial

Safety and Immunogenicity of a Self-Amplifying RNA Vaccine Against Crimean-Congo Hemorrhagic Fever

for Vaccine

1 location in San Antonio

Sponsor: HDT Bio

Sex: All·Age: 18 - 64·Accepts healthy volunteers

Code: NCT06799013·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Temsirolimus Adventitial Delivery to Improve ANGioplasty and/or Atherectomy Revascularization Outcomes Below the Knee

for Peripheral Artery Disease

Sites in Dallas +1 more location

Sponsor: Mercator MedSystems, Inc.

Sex: All·Age: 18+

Code: NCT04433572·Phase 3·Recruiting·Listed Jun 2020

Apply to this trial

A Study of LY3867070 in Healthy Participants

for Healthy

Sites in Dallas +1 more location

Sponsor: Eli Lilly and Company

Sex: All·Age: 18 - 65·Accepts healthy volunteers

Code: NCT07021547·Phase 1·Recruiting·Listed Jun 2025

Apply to this trial

A Study of Participants With Cerebral Adrenoleukodystrophy (CALD) Treated With Elivaldogene Autotemcel

for Cerebral Adrenoleukodystrophy (CALD)

Sites in Dallas +2 more locations

Sponsor: Genetix Biotherapeutics Inc.

Sex: Male·Age: All ages

Code: NCT06224413·Recruiting·Listed Jan 2024

Apply to this trial

A Study of the c-Kit Specific Antibody-Drug Conjugate NN3201 for Advanced and/or Metastatic Solid Tumors Known to Express c-Kit

for Gastrointestinal Stromal Tumors

Sites in Houston +3 more locations

Sponsor: Novelty Nobility, Inc.

Sex: All·Age: 18+

Code: NCT06805825·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial

Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix

for Cervical Cancer by FIGO Stage 2018

Sites in Dallas +4 more locations

Sponsor: Varian, a Siemens Healthineers Company

Sex: Female·Age: 18+

Code: NCT05197881·Recruiting·Listed Jan 2022

Apply to this trial

Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial

for Prostate Cancer

Sites in Austin +2 more locations

Sponsor: Palette Life Sciences, Inc.

Sex: Male·Age: 18+

Code: NCT06496256·Recruiting·Listed Jul 2024

Apply to this trial

Clinical Study of Anti-FLT3 CAR-T Cells for the Treatment of Relapsed/Refractory AML

for Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)

1 location in Houston

Sponsor: Hemogenyx Pharmaceuticals LLC

Sex: All·Age: 12+

Code: NCT06786533·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

Allogenic Hepatocyte Transplantation Into Periduodenal Lymph Nodes

for End Stage Liver Disease

1 location in Houston

Sponsor: LyGenesis, Inc.

Sex: All·Age: 18 - 70

Code: NCT04496479·Phase 2·Recruiting·Listed Aug 2020

Apply to this trial

ViewFlex X ICE First-in-Human Study

for Cardiac Arrhythmias

Sites in Houston +7 more locations

Sponsor: Abbott Medical Devices

Sex: All·Age: 18+

Code: NCT06772493·Recruiting·Listed Jan 2025

Apply to this trial

US National TOP Registry

for Lung Transplant

Sites in Houston, Dallas +5 more locations

Sponsor: TransMedics

Sex: All·Age: All ages

Code: NCT06513091·Recruiting·Listed Jul 2024

Apply to this trial

tAN for First Responders

for Mental Fatigue

1 location in Dallas

Sponsor: Spark Biomedical, Inc.

Sex: All·Age: 18+

Code: NCT07109349·Recruiting·Listed Aug 2025

Apply to this trial

A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel

for Beta-Thalassemia

Sites in Houston +5 more locations

Sponsor: Genetix Biotherapeutics Inc.

Sex: All·Age: All ages

Code: NCT06271512·Recruiting·Listed Feb 2024

Apply to this trial

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia, in Relapse

Sites in Houston +3 more locations

Sponsor: Bio-Path Holdings, Inc.

Sex: All·Age: 18+

Code: NCT05190471·Phase 1·Recruiting·Listed Jan 2022

Apply to this trial

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

for Acute Myeloid Leukemia (AML)

Drug: Venetoclax

Sites in Houston +5 more locations

Sponsor: Bio-Path Holdings, Inc.

Sex: All·Age: 18+

Code: NCT02781883·Phase 2·Recruiting·Listed May 2016

Apply to this trial

BP1001-A in Patients With Advanced or Recurrent Solid Tumors

for Solid Tumor, Adult

Sites in Houston, Dallas +2 more locations

Sponsor: Bio-Path Holdings, Inc.

Sex: All·Age: 18+

Code: NCT04196257·Phase 1·Recruiting·Listed Dec 2019

Apply to this trial

Study of IBI3020 Treatment in Participants With Late-Stage Solid Tumors

for Solid Tumors

Sites in Houston, Irving +4 more locations

Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.

Sex: All·Age: 18 - 75

Code: NCT06963281·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Pediatric Down Syndrome Post-Approval Study

for Pediatric Obstructive Sleep Apnea

Sites in Houston +5 more locations

Sponsor: Inspire Medical Systems, Inc.

Sex: All·Age: 13 - 18

Code: NCT06851338·Recruiting·Listed Feb 2025

Apply to this trial

A Study to Assess Safety and Efficacy of SOT201 in Patients With Advanced/Metastatic Cancer

for Advanced Solid Tumor

1 location in Houston

Sponsor: SOTIO Biotech AG

Sex: All·Age: 18+

Code: NCT06163391·Phase 1·Recruiting·Listed Dec 2023

Apply to this trial

Outcomes Following Combined Adductoplasty™ and Lapiplasty® (MTA3D)

for Metatarsus Adductus

Sites in Keller +8 more locations

Sponsor: Treace Medical Concepts, Inc.

Sex: All·Age: 14 - 65·Accepts healthy volunteers

Code: NCT05587569·Recruiting·Listed Oct 2022

Apply to this trial

To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation

for Advanced Solid Tumors

Sites in Houston +3 more locations

Sponsor: Abion Inc

Sex: All·Age: 18+

Code: NCT05541822·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

for Stargardt Disease

Sites in Dallas +4 more locations

Sponsor: Splice Bio

Sex: All·Age: 12 - 65

Code: NCT06942572·Phase 1, Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

A Phase II Clinical Study to Evaluate HLX43 in Subjects With Advanced Non-small Cell Lung Cancer (NSCLC)

for Non Small Cell Lung Cancer

1 location in Houston

Sponsor: Shanghai Henlius Biotech

Sex: All·Age: 18+

Code: NCT06907615·Phase 2·Recruiting·Listed Apr 2025

Apply to this trial

Study Assessing Left Ventricular Administration of a Genetic Medicine Directing Organ Regeneration in Heart Failure

for Heart Failure With Reduced Ejection Fraction

1 location in Houston

Sponsor: Medley Therapeutics

Sex: All·Age: 18 - 79

Code: NCT06831825·Phase 1·Recruiting·Listed Feb 2025

Apply to this trial